8.65MMarket Cap
LossP/E TTM
Adagio Medical Holdings Inc
Key Figures
0.399Open
0.403High
64.85KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.29%Turnover Ratio
0.374Prev. Close
0.370Low
16.11KTurnover
LossP/E Static
1.51P/B
0.00%Div Yield TTM
-60.43%ROA
2.58252wk High
0.55Volume Ratio
-75.04MNet Profit
22.21MShares
-1.3265EPS TTM
-0.18Beta
-268.88%ROE
0.70052wk Low
8.89%Amplitude
-1011.68%Gross Margin
8.65MMarket Cap
-6.19Reward/Risk
6.65%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Adagio Medical Holdings Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 74 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 3.33.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Adagio Medical Holdings Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Adagio Medical Holdings Inc Highlights
StrengthsRisks
Adagio Medical Holdings Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Adagio Medical Holdings Inc
ADGM
3
Intuitive Surgical Inc
ISRG
35
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
29
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Adagio Medical Holdings Inc Info
Adagio Medical Holdings, Inc. is a commercial stage medical device company. It is focused on developing proprietary Ultra-Low Temperature Cryoablation technology that creates contiguous, transmural lesions to treat cardiac arrhythmias, with an emphasis on ventricular tachycardia. It is developing and placing on the European Union (EU) market ablation technologies for the treatment of cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. Its product portfolio consists of three product families: iCLAS atrial ULTC catheter and accessories, vCLAS ventricular ULTC catheter, and Cryopulse atrial PFCA catheter and accessories. All of these catheters share the same ULTC cryoablation console. The iCLAS system is CE-marked with the indication for treatment of paroxysmal atrial fibrillation, persistent atrial fibrillation and atrial flutter. The vCLAS ventricular catheter has been specifically designed for the treatment of ventricular arrhythmia.
Ticker SymbolADGM
CompanyAdagio Medical Holdings Inc
CEOUsen (Todd)
Website
Shareholders
FAQs
What is the current price of Adagio Medical Holdings Inc (ADGM)?
The current price of Adagio Medical Holdings Inc (ADGM) is 0.39.
What is the symbol of Adagio Medical Holdings Inc?
The ticker symbol of Adagio Medical Holdings Inc is ADGM.
What is the 52-week high of Adagio Medical Holdings Inc?
The 52-week high of Adagio Medical Holdings Inc is 2.58.
What is the 52-week low of Adagio Medical Holdings Inc?
The 52-week low of Adagio Medical Holdings Inc is 0.70.
What is the market capitalization of Adagio Medical Holdings Inc?
The market capitalization of Adagio Medical Holdings Inc is 8.65M.
Is Adagio Medical Holdings Inc (ADGM) currently rated as Buy, Hold, or Sell?
According to analysts, Adagio Medical Holdings Inc (ADGM) has an overall rating of Buy, with a price target of 3.33.
What is the Earnings Per Share (EPS TTM) of Adagio Medical Holdings Inc (ADGM)?
The Earnings Per Share (EPS TTM) of Adagio Medical Holdings Inc (ADGM) is -1.51.
